418 related articles for article (PubMed ID: 17429861)
1. [Sentinel lymph node biopsy and incidence of recurrence].
Hautarzt; 2006 Mar; 57(3):182. PubMed ID: 17429861
[No Abstract] [Full Text] [Related]
2. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
[No Abstract] [Full Text] [Related]
3. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
[No Abstract] [Full Text] [Related]
4. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.
Pawlik TM; Ross MI; Thompson JF; Eggermont AM; Gershenwald JE
J Clin Oncol; 2005 Jul; 23(21):4588-90. PubMed ID: 16034040
[No Abstract] [Full Text] [Related]
5. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
[No Abstract] [Full Text] [Related]
6. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
Thomas JM; Clark MA
Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245
[TBL] [Abstract][Full Text] [Related]
7. [Study of variations between surgeons regarding inguinal lymph node clearance in melanoma].
Danino MA; Trost O; Malka G; Garrido I; Jebrane A; Dalac S
Ann Dermatol Venereol; 2008 Feb; 135(2):142-4. PubMed ID: 18342100
[No Abstract] [Full Text] [Related]
8. Current treatment of cutaneous melanoma and the sentinel lymph node.
Bruns SD; McGee JM; Phillips JW
J Okla State Med Assoc; 2002 May; 95(5):332-5. PubMed ID: 12043108
[No Abstract] [Full Text] [Related]
9. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
10. Lymph node assessment in melanoma.
Easson AM; Rotstein LE; McCready DR
J Surg Oncol; 2009 Mar; 99(4):176-85. PubMed ID: 19065639
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the RT-PCR positive sentinel node in melanoma.
Temple CL; Snell LJ; Power SM; Parfitt JR; Scilley C; Engel CJ; Shum D; Chakrabarti S; Joseph MG; Lohmann RC; Ainsworth P
J Surg Oncol; 2007 Jun; 95(7):546-54. PubMed ID: 17219388
[TBL] [Abstract][Full Text] [Related]
13. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
Thomas JM
J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
[No Abstract] [Full Text] [Related]
14. [Sentinel node biopsy between myth and reality].
Thomas M; Bahmer FA
J Dtsch Dermatol Ges; 2011 Nov; 9(11):919-21. PubMed ID: 22026359
[No Abstract] [Full Text] [Related]
15. Clinical classification and staging.
Gershenwald JE; Fischer D; Buzaid AC
Clin Plast Surg; 2000 Jul; 27(3):361-76, viii. PubMed ID: 10941558
[TBL] [Abstract][Full Text] [Related]
16. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Hartgrink HH; Van de Velde CJ
Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1311-2; author reply 1312. PubMed ID: 15279220
[No Abstract] [Full Text] [Related]
17. Pathobiology of the sentinel node.
Cochran AJ; Ohsie SJ; Binder SW
Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node mapping for melanoma: results of trials and current applications.
Thompson JF; Shaw HM
Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
[TBL] [Abstract][Full Text] [Related]
19. [For the benefit of the patient: the sentinel node excision].
Satzger I; Klein M; Löser C; Möhrle M; Reske S; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2011 Nov; 9(11):922-6. PubMed ID: 22026360
[No Abstract] [Full Text] [Related]
20. [Sentinel node diagnosis in malignant melanoma. Reflections on relapse after histologically negative sentinel node].
Abrahamsen HN; Larsen J; Hamilton-Dutoit SJ; Rasmussen K; Steiniche T
Ugeskr Laeger; 2003 Sep; 165(39):3735-6. PubMed ID: 14558388
[No Abstract] [Full Text] [Related]
[Next] [New Search]